Background:The 2019 (Covid19) pandemic of coronavirus disease was caused by SARS Cov 2 Virus. The emergence of the disease was started from the Wuhan city of China in December 20191. This infection causes asymptomatic and mild diseases more than severe pneumonia. A Rapid Lateral flow immunoassays using monoclonal anti-SARS CoV- 2 antibodies, targeting SARS-CoV-2 antigens, can be used as complementary screening tests if their accuracy comes comparable to that of gold standard real-time RT-PCR assays.
Alan : Sosyal, Beşeri ve İdari Bilimler
Dergi Türü : Uluslararası
Benzer Makaleler | Yazar | # |
---|
Makale | Yazar | # |
---|